TMPP
Latest Information Update: 23 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Porphyrins
- Mechanism of Action Angiogenesis inhibitors; Fibroblast growth factor inhibitors; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 Aug 2000 New profile
- 30 Aug 2000 Preclinical development for Cancer in Israel (Unknown route)